- Home
- S vs GRFS Comparison
S vs GRFS Comparison
Compare S & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- S
- GRFS
- Stock Information
- Founded
- S 2013
- GRFS 1940
- Country
- S United States
- GRFS Spain
- Employees
- S N/A
- GRFS N/A
- Industry
- S EDP Services
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- S Technology
- GRFS Health Care
- Exchange
- S Nasdaq
- GRFS Nasdaq
- Market Cap
- S 5.9B
- GRFS 6.2B
- IPO Year
- S 2021
- GRFS 2006
- Fundamental
- Price
- S $17.63
- GRFS $9.77
- Analyst Decision
- S Buy
- GRFS Hold
- Analyst Count
- S 29
- GRFS 1
- Target Price
- S $24.83
- GRFS $10.30
- AVG Volume (30 Days)
- S 5.5M
- GRFS 803.4K
- Earning Date
- S 08-26-2025
- GRFS 01-01-0001
- Dividend Yield
- S N/A
- GRFS N/A
- EPS Growth
- S N/A
- GRFS N/A
- EPS
- S N/A
- GRFS 0.31
- Revenue
- S $864,135,000.00
- GRFS $7,968,532,207.00
- Revenue This Year
- S $24.05
- GRFS $7.14
- Revenue Next Year
- S $20.71
- GRFS $7.16
- P/E Ratio
- S N/A
- GRFS $39.05
- Revenue Growth
- S 28.19
- GRFS 10.76
- 52 Week Low
- S $15.36
- GRFS $6.19
- 52 Week High
- S $29.29
- GRFS $10.00
- Technical
- Relative Strength Index (RSI)
- S 44.58
- GRFS 70.91
- Support Level
- S $17.18
- GRFS $9.70
- Resistance Level
- S $18.00
- GRFS $9.91
- Average True Range (ATR)
- S 0.52
- GRFS 0.21
- MACD
- S -0.02
- GRFS 0.06
- Stochastic Oscillator
- S 27.30
- GRFS 85.26
About S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.